Advancements include CosMx® 2.0 upgrade; CosMx same-slide multiomics; and multiomics capabilities on the nCounter® platform
CHICAGO, Illinois, April 25, 2025 – Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology and multiomics research at the 2025 American Association for Cancer Research (AACR) General Meeting. These new advancements build upon the innovations announced at AGBT, including launch of CosMx WTX assay for subcellular spatial imaging of the whole transcriptome, the PaintScape™ platform for visualization of 3D genome architecture and chromosomal structure in single cells, the PowerOMX™ engine for streamlined spatial proteomics analysis on the CellScape™ platform, and the 1,200-plex protein panel for GeoMx® DSP. Bruker Spatial Biology today announces the following innovations that underscore Bruker’s leading commitment to advancing spatial biology with pioneering, best-in-class platforms.
